The pharmaceutical industry relies heavily on a diverse range of organic intermediates to construct complex active pharmaceutical ingredients (APIs). Among these, 1,2-Dibromo-4-fluorobenzene (CAS: 2369-37-1) stands out as a valuable building block, offering unique reactivity due to its halogen substituents and fluorine atom. R&D scientists and chemists seeking to synthesize novel drug candidates often look to buy this compound for its versatility in various coupling reactions and functional group transformations.

The presence of two bromine atoms on adjacent carbons and a fluorine atom on the benzene ring makes 1,2-Dibromo-4-fluorobenzene an ideal starting material for creating complex aromatic structures. This is particularly useful in medicinal chemistry for the development of new therapeutic agents targeting a range of diseases. When sourcing this chemical, prioritizing high purity, typically 98% or 99%, is essential to ensure the efficiency and success of multi-step pharmaceutical synthesis pathways. Collaborating with established manufacturers and suppliers, especially those with a strong presence in China, can guarantee the quality and availability of this critical component.

Researchers often inquire about the price and availability of 1,2-Dibromo-4-fluorobenzene when planning their synthetic routes. A competitive price from a reliable supplier, coupled with consistent product quality, significantly impacts the cost-effectiveness of drug development. The chemical properties, such as its melting point of 69℃ and a molecular weight of 253.89, are standard parameters that scientists consider. Furthermore, a supplier’s ability to provide detailed technical data sheets and lot-specific Certificates of Analysis (CoA) is crucial for regulatory compliance and research integrity.

For pharmaceutical companies, securing a stable supply chain for intermediates like 1,2-Dibromo-4-fluorobenzene is as important as the chemical synthesis itself. Partnering with manufacturers who have a proven track record in producing fine chemicals ensures that production can scale smoothly from laboratory research to commercial manufacturing. By choosing to buy from dependable sources, the pharmaceutical sector can accelerate the discovery and delivery of life-saving medications, powered by the precise and efficient use of essential organic intermediates.